MedPath
FDA Approval

Potassium Chloride in Lactated Ringers and Dextrose

June 24, 2021

HUMAN PRESCRIPTION DRUG LABEL

Calcium chloride(0.2 g in 1000 mL)
Sodium chloride(6 g in 1000 mL)
Lactic acid(3.1 g in 1000 mL)
Potassium chloride(1.79 g in 1000 mL)
Glucose(50 g in 1000 mL)

Manufacturing Establishments (1)

Purac Biochem B.V.

ICU Medical Inc.

405232687

Products (1)

Potassium Chloride in Lactated Ringers and Dextrose

0990-7111

NDA019685

NDA (C73594)

INTRAVENOUS

June 24, 2021

Code: M4I0D6VV5MClass: ACTIBQuantity: 0.2 g in 1000 mL
Code: 451W47IQ8XClass: ACTIBQuantity: 6 g in 1000 mL
Code: TU7HW0W0QTClass: ACTIBQuantity: 3.1 g in 1000 mL
Code: 660YQ98I10Class: ACTIBQuantity: 1.79 g in 1000 mL
GlucoseActive
Code: LX22YL083GClass: ACTIBQuantity: 50 g in 1000 mL
WATERInactive
Code: 059QF0KO0RClass: IACT

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PRINCIPAL DISPLAY PANEL - 1000 mL Bag Label

20 mEq POTASSIUM ADDED

1000 mL
NDC 0990-7111-09

20
mEq
POTASSIUM
CHLORIDE

in Lactated Ringer's
and 5% Dextrose
Injection, USP

EACH 100 mL CONTAINS POTASSIUM CHLORIDE
179 mg; SODIUM CHLORIDE 600 mg; SODIUM
LACTATE, ANHYDROUS 310 mg; CALCIUM CHLORIDE,
DIHYDRATE 20 mg; DEXTROSE, HYDROUS 5 g IN
WATER FOR INJECTION. MAY CONTAIN HCl FOR
pH ADJUSTMENT. ELECTROLYTES PER 1000 mL
(NOT INCLUDING IONS FOR pH ADJUSTMENT):
POTASSIUM 24 mEq; SODIUM 130 mEq; CHLORIDE
129 mEq; CALCIUM 2.7 mEq; LACTATE 28 mEq.
563 mOsmol/LITER (CALC.)
pH 4.9 (3.5 to 6.5)
NOT FOR USE IN THE TREATMENT OF LACTIC ACIDOSIS.

ADDITIVES MAY BE INCOMPATIBLE. CONSULT WITH
PHARMACIST, IF AVAILABLE. WHEN INTRODUCING
ADDITIVES, USE ASEPTIC TECHNIQUE, MIX
THOROUGHLY AND DO NOT STORE.

SINGLE-DOSE CONTAINER. FOR I.V. USE.
USUAL DOSAGE: SEE INSERT. STERILE, NONPYROGENIC.
USE ONLY IF SOLUTION IS CLEAR AND CONTAINER
IS UNDAMAGED. MUST NOT BE USED IN SERIES
CONNECTIONS.

Rx ONLY
3
V
CONTAINS DEHP

IMP0000048

ICU Medical, Inc.,
Lake Forest, Illinois, 60045, USA
icumedical

PRINCIPAL DISPLAY PANEL - 1000 mL Bag Label


DESCRIPTION SECTION

DESCRIPTION

Intravenous solution with potassium chloride (I.V. solutions with KCl) is a sterile and nonpyrogenic solution in water for injection. This solution is for administration by intravenous infusion only.

See Table for summary of content and characteristics of this solution.

The solution contains no bacteriostat, antimicrobial agent or added buffer and is intended only for use as a single-dose injection. When smaller doses are required the unused portion should be discarded.

This solution is a parenteral fluid, nutrient and/or electrolyte replenisher.

Dextrose, USP is chemically designated D-glucose, monohydrate (C6H12O6 • H2O), a hexose sugar freely soluble in water. It has the following structural formula:

Structural Formula of Dextrose USP

Potassium Chloride, USP is chemically designated KCl, a white granular powder freely soluble in water.

Sodium Chloride, USP is chemically designated NaCl, a white crystalline powder freely soluble in water.

Calcium Chloride, USP is chemically designated calcium chloride dihydrate (CaCl2 • 2H2O), white fragments or granules freely soluble in water.

Sodium Lactate, USP is chemically designated monosodium lactate [CH3CH(OH)COONa], a 60% aqueous solution miscible in water. It has the following structural formula:

Structural Formula of Sodium Lactate USP

Water for Injection, USP is chemically designated H20.

The flexible plastic container is fabricated from a specially formulated polyvinylchloride. Water can permeate from inside the container into the overwrap but not in amounts sufficient to affect the solution significantly. Solutions in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the plastic container materials. Exposure to temperatures above 25°C/77°F during transport and storage will lead to minor losses in moisture content. Higher temperatures lead to greater losses. It is unlikely that these minor losses will lead to clinically significant changes within the expiration period.


HOW SUPPLIED SECTION

HOW SUPPLIED

Intravenous solution with potassium chloride (I.V. solution with KCl) is supplied in single-dose flexible plastic container. See Table:

Potassium Chloride

in Lactated Ringer’s

and 5% Dextrose

Injection, USP

List No.

mEq

Potassium

Added

Size

(mL)

COMPOSITION (g/L)

Calculated

Osmolarity

(mOsmol/L)

Dextrose,

Hydrous

Potassium

Chloride

Sodium

Chloride

Sodium

Lactate,

Anhydrous

Calcium

Chloride

Dihydrate

7111

20 mEq

1000

50

1.79

6

3.1

0.2

563

NDC No.

0409-7111-09

0990-7111-09

Potassium Chloride

in Lactated Ringer’s

and 5% Dextrose

Injection, USP (Continued)

pH

Approx. Ionic Concentrations (mEq/L)

Approx.

kcal/L

Calcium

(Ca++)

Sodium

(Na**+****)**

Potassium

(K**+****)**

Chloride

(Cl¯)

Lactate

4.9

(3.5 to 6.5)

2.7

130

24

129

28

179

ICU Medical is transitioning NDC codes from the "0409" to a "0990" labeler code. Both NDC codes are expected to be in the market for a period of time.

May contain HCl for pH adjustment.

Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.] Protect from freezing.

Revised: March, 2020

IFU0000167

ICU Medical, Inc., Lake Forest, Illinois, 60045, USA


© Copyright 2025. All Rights Reserved by MedPath